HB Wealth Management »

Biomarin Pharmaceutical shares owned by HB Wealth Management

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by HB Wealth Management from 13F filings

Historical chart of HB Wealth Management investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by HB Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by HB Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $11k 11k 0.95
2025-06-30 $10k 11k 0.94
2025-03-31 $10k 11k 0.94
2024-12-31 $10k 11k 0.93
2024-09-30 $10k 11k 0.95
2024-06-30 $11k 11k 0.96

More positions owned by HB Wealth Management

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
American Centy Etf Tr Us Eqt Etf (AVUS)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Apple Put Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr S&p 500 Grwt Etf (IVW)
Home Depot (HD)
Microsoft Corporation Put Option (MSFT)
NVIDIA Corporation Put Option (NVDA)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)

View all positions for HB Wealth Management

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Ing Investment Management
BlackRock
MacKay Shields
Opti Capital Management
Capstone Investment Advisors
Wellesley Investment Advisors
Millennium Management
Lazard Asset Management
Oaktree Capital Management
Victory Capital Management
Bnp Paribas Arbitrage, Snc
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Biomarin Pharmaceutical